Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Unternehmens-codeISRG
Name des UnternehmensIntuitive Surgical Inc
IPO-datumJun 13, 2000
Gegründet am1995
CEODr. Gary S. Guthart, Ph.D.
Anzahl der mitarbeiter15638
WertpapierartOrdinary Share
GeschäftsjahresendeJun 13
Addresse1020 Kifer Road
StadtSUNNYVALE
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl94086
Telefon14085232100
Websitehttps://www.intuitive.com/en-us/about-us/company
Unternehmens-codeISRG
IPO-datumJun 13, 2000
Gegründet am1995
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten